This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biopharmx, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovative Mind of Robert Kehl Sink
Introduction
Robert Kehl Sink, based in Sunnyvale, California, is an inventive mind in the pharmaceutical landscape. With one patent to his name, his contributions to the field of medicine are noteworthy, particularly in addressing health concerns through innovative medical formulations.
Latest Patents
Sink's most significant patent is the "Solid Oral Dosage Form for Breast Symptoms." This invention is a groundbreaking solid oral dosage designed to deliver a supraphysiological dose of molecular iodine ranging from 3 to 60 mg per day. One of its key advantages is the low risk of thyroid-related adverse clinical events for patients who experience deficiencies of certain minerals. The formulation includes a source of iodine, a reactive agent, and essential minerals such as calcium or iron. Additionally, it may comprise beneficial vitamins and compounds, including selenium, vitamin A, vitamin D, zinc, gamma-linolenic acid, vitamin B1, and magnesium. Notably, this dosage form may also have an enteric coating, designed to protect ingredients that are primarily absorbed from the intestines, ensuring optimal delivery of the medicinal benefits.
Career Highlights
Robert Kehl Sink has made significant strides in his career, currently working with Biopharmx, Inc. His role involves spearheading innovative research projects aimed at developing effective solutions for various health issues.
Collaborations
In his endeavors, Sink collaborates with notable colleagues, including Jack H. Kessler. These collaborations are vital for the advancement of their joint research initiatives and play a crucial role in bringing innovative products to market.
Conclusion
Robert Kehl Sink stands as a testament to the power of innovation in the pharmaceutical industry. His patent for a solid oral dosage form not only reflects his dedication to improving health outcomes but also highlights the importance of research and development in creating effective medical solutions. As he continues to work at Biopharmx, Inc., the industry eagerly anticipates future contributions that will emerge from his inventive spirit.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile